期刊文献+

儿童侵袭性纤维瘤中β-catenin的表达和基因突变分析及与复发相关性实验研究 被引量:2

Experimental study of relations of β-catenin expression and gene mutation and tumor recurrence in pediatric aggressive fibromatosis
下载PDF
导出
摘要 目的分析儿童侵袭性纤维瘤病β-catenin的表达和突变状态,并探讨其与肿瘤复发的相关性。方法搜集该院2007年6月—2013年5月期间手术留取侵袭性纤维瘤标本,应用免疫组化法对32例侵袭性纤维瘤病患儿(21例复发和11原发性发病例)和15例对照组进行分析。在β-catenin的3号外显子的体细胞点突变进行聚合酶链反应产物的测序。结果在侵袭性纤维瘤病样本中检测β-catenin的核表达为94%(30/32),而对照组为13%(2/15)(P<0.001)。在侵袭性纤维瘤病样本中B连环蛋白基因3号外显子突变率为78%(25/32)(19/21复发病例,6/11原发发病例;P=0.032)。在复发病例主要发生突变的密码子是45(S45F),而原发病例中41号密码子(T41A)是最常见的突变(P=0.002)。结论在β-catenin基因中,3号外显子的改变,特别是S45F突变,可以作为儿童患者复发的危险因素和可能被用作预后因素。 Objective To analyze the expression and mutation status of β-catenin in pediatric aggressive fibromatosis and explore the relation with tumor recurrence.Method Beta-catenin expression was analyzed by immunohistochemistry in 32 samples from pediatric patients with aggressive fibromatosis (21 recurrent cases and 11 primary -onset cases)and 15 control subjects.Somatic point mutations in β-catenin exon 3 were identified by sequencing of polymerase chain reaction products.Results Nuclear expression of β-catenin was detected in 94% (30 /32)of aggressive fibromatosis samples and 13% (2 /15)of control samples (P =0.001).Mutations in ex-on 3 of the β-catenin gene were identified in 78% (25 /32)of aggressive fibromatosis samples (19 /21 recurrent cases,6 /11 primary-onset cases;P =0.032).The primary mutation in the recurrent cases occurred at codon 45 (S45F),while codon 41 (T41A)was most frequently mutated in the primary -onset cases (P =0.002).Conclusion Mutations in exon 3 of the β-catenin gene,particular-ly the S45F mutation,may represent risk factors for recurrence in pediatric patients and could potentially be used as prognostic factors.
出处 《安徽医药》 CAS 2015年第8期1491-1494,共4页 Anhui Medical and Pharmaceutical Journal
基金 安徽省卫生厅医学科研项目(No 14FR016)
关键词 侵袭性纤维瘤 儿童 Β-CATENIN 基因突变 β-catenin aggressive fibromatosis children β-catenin gene mutation
  • 相关文献

参考文献20

  • 1Kallam AR, Ramakrishna BV, Roy GK,et al. Desmoid tumours: our experience of six cases and review of literature [ J ]. J Clin Di- agn Res,2014,8(10) :1 -4.
  • 2Prodinger PM, Rechl H, Keller M ,et al. Surgical resection and ra- diation therapy of desmoid turnouts of the extremities:results of a supra - regional tumour centre [ J ]. Int Orthop, 2013,37 ( 10 ) : 1987 - 1993.
  • 3Bertani E, Testori A, Chiappa A, et al, Recurrence and prognostic factors in patients with aggressive fibromatosis. The role of radical surgery and its limitations [ J ]. World J Surg Oncol, 2012, 10 (10) :184.
  • 4Ramamurthy R, Arumugam B, Ramanandham B. Recurrence pat- terns and management options in aggressive fibromatosis[ J]. Indi- an J Surg Oneo1,2012,3 (3) :222 -227.
  • 5Dao A,Benchakroun N ,Jabir H,et al. Five years of local control of subscapulafis aggressive fibromatosis managed by surgery and ima- tinib:a case report[J]. J Med Case Rep,2014,9(8) :416.
  • 6Gillers BS, Chiplunkar A, Aly H, et al. Canonical wnt signaling regulates atrioventrieular junction programming and electrophysio- logical properties[ J]. Circ Res ,2015,116 ( 3 ) :398 - 406.
  • 7Umbreit C, Flanjak J, Weiss C, et al. Incomplete epithelial -mes- enchymal transition in pl6-positive squamous cell carcinoma ceils correlates with beta-catanin expression [ J ]. Anticancer Res,2014, 34(12) :7061 -7069.
  • 8McEwen AE, Maher MT, Mo R,et al. E - cadherin phosphorylation occurs during its biosynthesis to promote its cell surface stability and adhesion[ J]. Mol Biol Cell,2014,25 (16) :2365 -2374.
  • 9李小燕,卢可,张志,廖东卫.E-cadherin在小肠腺癌、小肠腺瘤中的表达及其意义[J].安徽医药,2014,18(11):2112-2114. 被引量:3
  • 10张守武,邓跃华.JAB1、β-catenin与大肠癌生物学行为之间的关系[J].安徽医药,2014,18(9):1671-1674. 被引量:3

二级参考文献22

  • 1Edith P. Mitchell targeted therapy for metastatic colorectal cancer [J] . Role of Aflibercept Review Article Clinical Colorectal Caneer,2013,12(2) :73 -85.
  • 2Maruyama K, Ochiai A, Akimoto S, et al. Cytoplasmic beta-catenin accmulation as a predictor of hematogenuous metagenous metastasis in human colorectal cancer[J] . Oncology,2000,59(4) :302 -309.
  • 3Zhou J , Wan B, Li R, et al. JAB1 interacts with brain-specific kinase 2 (BRSK2) and promotes its degradation in the ubiquitin - proteasome pathway [J] . Biochemical and Biophysical Research Communications,422(4) :647 -652.
  • 4Nishimoto A,Lu L,Hayashi M,et al. JABI regulates levels of endothelin type A and B receptors by promoting ubiquitination and degradation[J] . Biochem Biophys Res Commun,2010,391 (4): 1616 -1622.
  • 5Cayli S,Eyibilen A, Gurbuzler L,et al. JABI expression is associated with TGF -131 signaling in chronic rhinosinusitis and nasal polyposis [J] . Acta Histochemica, 20 12 , 114 (I ) : 12 - 17 .
  • 6Kleemann R, Hausser A, Geiger G, et al. Intracellular action of the cytokine MIF to modulate AP-I activity and the cell cycle through JAB1 [J] . Nature,2000,408(6809) :211 -216.
  • 7Shackleford TJ, Claret FX. JABIICSN5: a new player in cell cycle control and cancer] J] . Cell Div ,2010,5 :26.
  • 8Monga SP. Role of Wntll3-catenin signaling in liver metabolism and cancer [J] . Int J Biochem Cell Bioi ,2011,43(7) :1021-1029.
  • 9Zhang N , Wei P , Gong A, et al. FoxMI promotes j3-catenin nuclear localization and controls W nt target -gene expression and glioma tumorigenesis [J] . Cancer Cell, 20 II ,20 ( 4 ) : 427 - 442.
  • 10Schlitz AK,Hennes T,Jumpertz S,et al. Role of CSN5/JAB1 in Wntll3-catenin activation in colorectal cancer cells [J] . FEBS Letters,2012,586( II) :1645 -1651.

共引文献4

同被引文献7

引证文献2

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部